Skip to main content

MoneyWorks4Me

AstraZeneca Pharma India informs about unaudited financial results

06 Feb 2018 Evaluate

AstraZeneca Pharma India has informed about the Board Meeting of the Company held on Monday, February 5, 2018, has considered and approved the Unaudited Financial Results of the Company for the quarter ended December 31, 2017.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..